Economic impact of Diabetes #3

Health Expenditures for Diabetes

New estimates for 2010 and 2030. In 2003, the second edition of the IDF Diabetes Atlas presented the first worldwide tables of country-specific estimates of expenditures for health and healthcare caused by diabetes. These estimates were generated using a formula that combined estimates of national health spending, the prevalence of diabetes by country, and the ratio of diabetic to non-diabetic medical care expenses (“R”) [1]. A single R value and a single value for countrywide per capita health expenditures were used for the estimates. In 2006, in the third edition of the Diabetes Atlas, these country-specific estimates were improved by using different values for R and per capita health expenditures for each of 42 different subgroups, divided by age and sex within each country. Expenditure estimates nearly doubled using the more precise formula. The same method used in the third edition was utilized in this edition. The Appendix details and critiques the formula and the data.

How to read the tables of health expenditures. Table 1 summarizes the new estimates on total and per capita expenditure on diabetes and the total spending on diabetes as the proportion of the total health expenditure for the world and each of the IDF regions. Table 2 shows the estimated total expenditure on diabetes by region, age, and sex. Tables 3 to 9 display the same information as Table 1 but for every country by IDF region. The cost estimates are for both years 2010 and 2030. The estimated total expenditure for diabetes is the expenditure attributable to diabetes not the total health expenditures spent on persons with diabetes. Similarly, the estimated per capita expenditure is the healthcare resources a person with diabetes consumed because of their diabetes condition, not their total heath annual expenditure.

Estimates are shown in both United States Dollar (USD) and in International Dollar (ID). US dollars are best used to compare currency prices or expenditures for diabetes care. International dollars are best used to compare the amount of diabetes care that countries produce. The International Dollar is a USD that has been adjusted to account for differences in purchasing power, as estimated from surveys of how much the USD buys of a standard basket of goods and services in different countries. Amounts in both USD and ID are expressed as of their value in 2005, the most recent year for which national health expenditure estimates have been published [2].

Estimates are shown at two values of the diabetes cost ratio, R. R is the ratio of medical care expenditures for persons with diabetes to age- and sex-matched persons without diabetes. R is the key parameter in the conversion of per capita health spending into estimates of spending caused by diabetes. Based on current evidence, which is very limited, we think that R rarely falls below 2.0 in any country and usually does not exceed 3.0. In the industrialized countries of North America, Europe, and the Western Pacific, R has probably been falling, and a value
closer to 2 should be assumed [3, 4]. In other countries, it is impossible as yet to recommend a ratio.

See the Appendix for details in link below.....

http://blogimages.bloggen.be/diabetescheck/attach/35597.pdf

http://www.depsyl.com/

http://back2basicnutrition.com/

http://bionutritionalresearch.olhblogspace.com/